Jane Street
NRXP icon

Jane Street’s NRX Pharmaceuticals NRXP Stock Holding History

Jane Street’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78K Buy
36,600
+6,000
+20% +$12.1K ﹤0.01% 10760
2025
Q4 		$82.9K Buy
30,600
+18,500
+153% +$49.7K ﹤0.01% 10282
2025
Q3 		$39.9K Buy
+12,100
New +$34.6K ﹤0.01% 10404
2022
Q1 		– Sell
-5,500
Closed -$263K – 10798
2021
Q4 		$263K Sell
5,500
-2,070
-27% -$149K ﹤0.01% 8409
2021
Q3 		$702K Buy
+7,570
New +$985K ﹤0.01% 6639

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's NRXP Position: Q1 2026 in Review

Jane Street increased its NRX Pharmaceuticals (NRXP) stake by 16% in Q1 2026, buying an estimated $12.3K and bringing the position to 44,152 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #10682.

Jane Street first reported a position in NRXP in Q1 2021 and has held it in 8 quarters since. The position peaked at $714K in Q3 2021. 33 funds tracked by Wall St. Rank hold NRXP as of Q1 2026.

  • Jane Street held 44,152 shares of NRX Pharmaceuticals worth $94K as of Q1 2026.
  • Jane Street bought 6,087 NRX Pharmaceuticals shares in Q1 2026, an estimated $12.3K.
  • NRX Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10682 holding.
  • Jane Street first reported a position in NRX Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • Jane Street's NRX Pharmaceuticals position peaked at $714K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.